Menu
English
Stock Code: 00512.HK

Information Disclosure

Home
Information Disclosure

Contact Us

Units 3302, 33/F, The Center, 99 Queen's Road Central, Hong Kong

ir@grandpharm.com

www.grandpharm.com

Pages Links

Company Profile

Investor Relations

Legal Statement

Recent News

GP (HK)’s Global Innovative Drug STC3141 Successfully Dosed the First Patient of its Phase Ib Clinical Trial for ARDS In China, Deepen the Dual-Cycle Development Strategy and Continues the Global Development Process

2021-11-10
GP (HK)’s Global Innovative Drug Ryaltris Compound Nasal Spray Has Been Granted Phase Three Clinical Trial Approval, Enriches the Group’s Product Pipeline, and Consolidates its Competitive Advantage in the field of Respiratory & ENT

2021-10-21

© 2021. Grand Pharmaceutical Group Limited All Rights Reserved.